Business

Walmart E-Commerce To Rise 40% of an Undisclosed Number

When Walmart Inc. (NYSE: WMT) reported second-quarter results Thursday morning, the company's stock soared 10%. In guidance for the last half of its 2019 fiscal year, Walmart reaffirmed a previous ...
Read Full Story »

How Nordstrom Knocked It Out of the Park in Q2

When Nordstrom Inc. (NYSE: JWN) reported its most recent quarterly results after the markets closed on Thursday, the department store chain said that it had $0.95 in earnings per share ...
Read Full Story »

Aretha Franklin Sold 75 Million Albums

There has been no greater American popular singer than Aretha Franklin. It is difficult to imagine that there ever will be. We're not talking about sales here, but a hard-to-define ...
Read Full Story »

Walmart Extends Grocery Dominance as Whole Foods Has Too Few Stores

Part of Walmart Inc.'s (NYSE: WMT) earnings success was its ongoing surge in grocery sales. It continues to be a dominant force in the industry. One of its primary advantages ...
Read Full Story »

5 Most Important Things in Business Today

Tesla Inc. (NASDAQ: TSLA) faces accusations it spied on workers. According to Reuters: An employee fired from Tesla Inc’s Nevada battery factory filed a whistleblower complaint with the U.S. Securities ...
Read Full Story »

JC Penney Analyst Downgrade Brigade Looks Atrocious

J.C. Penney Co. Inc. (NYSE: JCP) is in the midst of a crisis. After poor earnings rattled the stock, most of its investors and customers have to be imagining whether ...
Read Full Story »

As Crocs Closes Factories, Who Will Make Its Shoes?

Crocs Inc. (NASDAQ: CROX), the maker of odd, casual shoes, posted reasonable earnings. It also said it would shutter all of its manufacturing operations. What it did not say is ...
Read Full Story »

Are Teva and Mylan Entering an EpiPen Price War to Zero?

Mylan N.V. (NASDAQ: MYL) has had a stranglehold on the market for EpiPen, but this is all changing after the U.S. Food and Drug Administration (FDA) approved Teva Pharmaceutical Ltd. ...
Read Full Story »

New Osteoarthritis Treatment Could Precipitate Another Blockbuster Drug

Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) and Regeneron Pharmaceuticals Inc. (NASDAQ: REGN) both saw handy gains on Thursday after the companies posted positive topline results from their late-stage trial of ...
Read Full Story »

The Driving Force for Even Higher Growth at Lululemon Might Not Be What You Think

Should analysts indefinitely chase up their ratings and targets on companies they follow? It's rather complicated, but this is a scenario that many investors find themselves contemplating if they have ...
Read Full Story »

Why Canopy Growth Received a Speculative Buy Analyst Rating With Big Upside

Wednesday's market sell-off may have gone unnoticed by investors who have opted to invest in (or speculate in) some of the more widely known cannabis companies. Canopy Growth Corp. (NYSE: ...
Read Full Story »

Vertex Wins FDA Approval for Expanded Cystic Fibrosis Treatment

Vertex Pharmaceuticals Inc. (NASDAQ: VRTX) shares saw a handy gain on Thursday after the U.S. Food and Drug Administration (FDA) gave the nod to Vertex’s cystic fibrosis (CF) treatment. Essentially, ...
Read Full Story »

Ford Shares Drop Below $10 as Chairman Bill Ford’s Turnaround Fails

The stock of Ford Motor Co. (NYSE: F) has dropped below $10 a share, another milestone that marks the car company's failure to set and institute plans for a turnaround. ...
Read Full Story »

US Drivers Learn More About Self-Driving Cars, Like Them Less

Over the past two years, U.S. drivers have become more aware of autonomous (self-driving) vehicles. More than three-quarters (78%) have some knowledge of autonomous vehicles that a human driver may ...
Read Full Story »

Why Summit Therapeutics Is One of Thursday’s Top Biotechs

Summit Therapeutics PLC (NASDAQ: SMMT) shares made a solid gain early on Thursday after the firm announced that it was awarded an additional $12 million under its contract with the ...
Read Full Story »